1128790

Felipe Samaniego, M.D. — FEI 3017124468

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)